Overview
- TickerPAIYY on OTC2
- IndustryServices-Specialty Outpatient Facilities, NEC2
- HeadquartersGrand Cayman, Cayman Islands2
- Incorporated inCayman Islands3
- Business address1122 Nanshan Avenue, Nanshan District, Shenzhen, 5180003
- Filer categoryNon-accelerated filer3
- Legal formcompany limited by shares2
- LEI549300Z17PKDH79BWD302
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O Vistra (Cayman) Limited, KY1-1205 Grand Cayman, Cayman Islands2
See how the biggest companies compare on our leaderboards
Medical Technology Co., Ltd. in June 2024. Additionally, Newa Medical Aesthetic Limited was deregistered in February 2025.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.10
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | 722.9M CNY | 755.7M CNY | 682.6M CNY |
| Cost of sales and services rendered | -388.6M CNY | -417.9M CNY | -360.5M CNY |
| Gross profit | 334.2M CNY | 337.8M CNY | 322.0M CNY |
| Selling expenses | -226.4M CNY | -241.0M CNY | -232.3M CNY |
| General and administrative expenses | -102.7M CNY | -100.8M CNY | -138.6M CNY |
| Operating result | 5.2M CNY | -4.0M CNY | -48.8M CNY |
| Finance income | 138.0K CNY | 404.0K CNY | 78.0K CNY |
| Finance costs | -8.7M CNY | -8.7M CNY | -14.5M CNY |
| Other gains/(losses), net | -20.8M CNY | -1.1M CNY | 8.4M CNY |
| Fair value loss of convertible note | 0 CNY | 0 CNY | -116.0K CNY |
| Fair value (loss)/gain of investment properties | -31.0K CNY | 12.1M CNY | -154.0K CNY |
| Impairment of goodwill | -500.0K CNY | 0 CNY | 0 CNY |
| Loss before income tax | -24.7M CNY | -1.3M CNY | -55.1M CNY |
| Income tax credit/(expense) | -29.3M CNY | -23.7M CNY | 15.1M CNY |
| Loss for the year | -54.1M CNY | -25.1M CNY | -39.9M CNY |
| Currency translation differences | 1.5M CNY | -302.0K CNY | -790.0K CNY |
| Revaluation of investment properties upon transfer from property, plant and equipment | 0 CNY | 0 CNY | -1.5M CNY |
| Total other comprehensive (loss)/income for the year, net of tax | 1.5M CNY | -302.0K CNY | -2.3M CNY |
| Total comprehensive loss for the year | -52.6M CNY | -25.4M CNY | -42.2M CNY |
| Owners of the Company | -53.3M CNY | -19.9M CNY | -37.4M CNY |
| Non-controlling interests | -721.0K CNY | -5.1M CNY | -2.5M CNY |
| Basic (in Yuan Renminbi per share) | -0.40 CNY | -0.14 CNY | -0.28 CNY |
| Diluted (in Yuan Renminbi per share) | -0.40 CNY | -0.14 CNY | -0.28 CNY |
| Owners of the Company | -51.8M CNY | -20.2M CNY | -39.7M CNY |
| Non-controlling interests | -721.0K CNY | -5.1M CNY | -2.5M CNY |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.10
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Property, plant and equipment | 279.5M CNY | 266.2M CNY | 304.2M CNY | |
| Investment properties | 35.0M CNY | 35.1M CNY | 22.9M CNY | |
| Intangible assets | 31.6M CNY | 36.6M CNY | 36.9M CNY | |
| Prepayments and deposits | 7.1M CNY | 6.7M CNY | ||
| Deferred income tax assets | 23.3M CNY | 53.6M CNY | ||
| Total non-current assets | 376.5M CNY | 398.1M CNY | ||
| Inventories | 18.8M CNY | 14.9M CNY | ||
| Trade receivables | 6.4M CNY | 8.8M CNY | ||
| Other receivables, deposits and prepayments | 42.2M CNY | 18.4M CNY | ||
| Amounts due from related parties | 1.7M CNY | 2.2M CNY | ||
| Restricted cash | 5.1M CNY | 1.0M CNY | ||
| Cash and cash equivalents | 60.3M CNY | 42.8M CNY | ||
| Total current assets | 134.4M CNY | 88.1M CNY | ||
| Total assets | 510.9M CNY | 486.2M CNY | ||
| Share capital | 998.0K CNY | 998.0K CNY | ||
| Treasury shares | -2.0M CNY | -2.0M CNY | ||
| Accumulated losses | -1.3B CNY | -1.2B CNY | ||
| Other reserves | 1.2B CNY | 1.2B CNY | ||
| Total equity attributable to owners of parent | -20.6M CNY | 30.5M CNY | ||
| Non-controlling interests | -22.6M CNY | -21.1M CNY | ||
| Total equity | -43.2M CNY | 9.3M CNY | 33.6M CNY | -125.9M CNY |
| Borrowings | 15.2M CNY | 13.7M CNY | ||
| Lease liabilities | 110.4M CNY | 61.1M CNY | ||
| Total non-current liabilities | 125.6M CNY | 74.8M CNY | ||
| Trade payables | 34.7M CNY | 48.4M CNY | ||
| Accruals, other payables and provisions | 42.4M CNY | 43.1M CNY | ||
| Contract liabilities | 186.1M CNY | 193.9M CNY | ||
| Borrowings | 129.1M CNY | 72.2M CNY | ||
| Lease liabilities | 25.9M CNY | 32.3M CNY | ||
| Current income tax liabilities | 10.3M CNY | 12.1M CNY | ||
| Total current liabilities | 428.6M CNY | 402.0M CNY | ||
| Total liabilities | 554.1M CNY | 476.9M CNY | ||
| Total equity and liabilities | 510.9M CNY | 486.2M CNY |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Property, plant and equipment | 279.5M CNY | 266.2M CNY | 304.2M CNY | |
| Investment properties | 35.0M CNY | 35.1M CNY | 22.9M CNY | |
| Intangible assets | 31.6M CNY | 36.6M CNY | 36.9M CNY | |
| Prepayments and deposits | 7.1M CNY | 6.7M CNY | ||
| Deferred income tax assets | 23.3M CNY | 53.6M CNY | ||
| Total non-current assets | 376.5M CNY | 398.1M CNY | ||
| Inventories | 18.8M CNY | 14.9M CNY | ||
| Trade receivables | 6.4M CNY | 8.8M CNY | ||
| Other receivables, deposits and prepayments | 42.2M CNY | 18.4M CNY | ||
| Amounts due from related parties | 1.7M CNY | 2.2M CNY | ||
| Restricted cash | 5.1M CNY | 1.0M CNY | ||
| Cash and cash equivalents | 60.3M CNY | 42.8M CNY | ||
| Total current assets | 134.4M CNY | 88.1M CNY | ||
| Total assets | 510.9M CNY | 486.2M CNY | ||
| Share capital | 998.0K CNY | 998.0K CNY | ||
| Treasury shares | -2.0M CNY | -2.0M CNY | ||
| Accumulated losses | -1.3B CNY | -1.2B CNY | ||
| Other reserves | 1.2B CNY | 1.2B CNY | ||
| Total equity attributable to owners of parent | -20.6M CNY | 30.5M CNY | ||
| Non-controlling interests | -22.6M CNY | -21.1M CNY | ||
| Total equity | -43.2M CNY | 9.3M CNY | 33.6M CNY | -125.9M CNY |
| Borrowings | 15.2M CNY | 13.7M CNY | ||
| Lease liabilities | 110.4M CNY | 61.1M CNY | ||
| Total non-current liabilities | 125.6M CNY | 74.8M CNY | ||
| Trade payables | 34.7M CNY | 48.4M CNY | ||
| Accruals, other payables and provisions | 42.4M CNY | 43.1M CNY | ||
| Contract liabilities | 186.1M CNY | 193.9M CNY | ||
| Borrowings | 129.1M CNY | 72.2M CNY | ||
| Lease liabilities | 25.9M CNY | 32.3M CNY | ||
| Current income tax liabilities | 10.3M CNY | 12.1M CNY | ||
| Total current liabilities | 428.6M CNY | 402.0M CNY | ||
| Total liabilities | 554.1M CNY | 476.9M CNY | ||
| Total equity and liabilities | 510.9M CNY | 486.2M CNY |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.10
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash generated from/(used in) operations | -10.8M CNY | 80.2M CNY | 74.3M CNY |
| Income tax paid | -1.4M CNY | -523.0K CNY | -20.0K CNY |
| Net cash generated from/(used in) operating activities | -12.2M CNY | 79.7M CNY | 74.3M CNY |
| Proceeds from disposal of property, plant and equipment | 6.6M CNY | 66.0K CNY | 11.0K CNY |
| Purchase of and deposit paid for property, plant and equipment | -6.9M CNY | -30.6M CNY | -55.2M CNY |
| Purchase of and deposit paid for intangible assets | -76.0K CNY | -187.0K CNY | -215.0K CNY |
| Restricted cash | 0 CNY | 0 CNY | 1.5M CNY |
| Balances with related parties | 0 CNY | 0 CNY | 717.0K CNY |
| Loan granted to a third party | -39.7M CNY | -66.0M CNY | 0 CNY |
| Loan repayment from the third party | 39.7M CNY | 66.0M CNY | 0 CNY |
| Interest income received | 138.0K CNY | 404.0K CNY | 78.0K CNY |
| Proceeds from disposal of associate | 0 CNY | 0 CNY | 80.0K CNY |
| Proceeds from disposal of subsidiaries | 0 CNY | 0 CNY | 824.0K CNY |
| Proceeds from ceased operation of subsidiaries | 0 CNY | -1.0K CNY | -44.0K CNY |
| Net cash used in investing activities | -279.0K CNY | -30.3M CNY | -52.2M CNY |
| Proceeds from borrowings | 80.2M CNY | 67.0M CNY | 85.2M CNY |
| Repayment of borrowings | -21.9M CNY | -63.0M CNY | -130.2M CNY |
| Repayment of lease liabilities | -38.8M CNY | -38.8M CNY | -25.7M CNY |
| Proceeds from other borrowings | 83.0M CNY | 92.1M CNY | 13.5M CNY |
| Repayment of other borrowings | -63.0M CNY | -116.3M CNY | -73.1M CNY |
| Interest paid | -8.7M CNY | -8.7M CNY | -10.1M CNY |
| Addition of paid-in capital | 0 CNY | 0 CNY | 170.0M CNY |
| Capital contribution from non-controlling interests | 0 CNY | -500.0K CNY | 0 CNY |
| Dividends paid to non-controlling interests | -801.0K CNY | -225.0K CNY | -546.0K CNY |
| Net cash generated from/(used in) financing activities | 29.9M CNY | -68.5M CNY | 29.1M CNY |
| Net increase/(decrease) in cash and cash equivalents | 17.4M CNY | -19.2M CNY | 51.1M CNY |
| Effect of changes in foreign exchange rates | 0 CNY | -302.0K CNY | -927.0K CNY |
No quarter-by-quarter statement was filed.
Compare Aesthetic Medical International Holdings Group Ltd with another company
Corporate structure
Aesthetic Medical International Holdings Group Ltd sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Aesthetic Medical International Holdings Group Ltd
- Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) Filed SCHEDULE 13D/A on Aesthetic Medical International Holdings Group Ltd, latest Apr 3, 2026 (4 filings since Jul 29, 2022)
- Australia Wanda International Co Ltd Filed SC 13D/A on Aesthetic Medical International Holdings Group Ltd, latest Dec 13, 2024
- Peak Asia Investment Holdings V Ltd Filed SC 13D/A on Aesthetic Medical International Holdings Group Ltd, latest Aug 17, 2023 (2 filings since Jul 29, 2022)
- Pengwu Zhou Filed SC 13D on Aesthetic Medical International Holdings Group Ltd, latest Jul 29, 2022
- Wenting Ding Filed SC 13D on Aesthetic Medical International Holdings Group Ltd, latest Jul 29, 2022
- Hainan Runming Biotechnology Co., Ltd. Filed SC 13D/A on Aesthetic Medical International Holdings Group Ltd, latest Jul 14, 2022 (2 filings since Jun 10, 2022)
- IDG-Accel China Growth Fund III L.P. Filed SC 13G/A on Aesthetic Medical International Holdings Group Ltd, latest Feb 28, 2022 (2 filings since Feb 28, 2022)
- Aesthetic Medical International Holdings Group Ltd Grand Cayman, Cayman Islands
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Aesthetic Medical International Holdings Group Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Real estate and locations
| Item | Latest | A year before | Change |
|---|---|---|---|
| Real estate investments, net | 35.1M CNY9 Dec 31, 2024 | 22.9M CNY9 Dec 31, 2023 | +53.0% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | 42.8M CNY9 Dec 31, 2024 | 62.3M CNY9 Dec 31, 2023 | −31.3% |
Inventory
Filings
72 filings to the SEC since October 2021: 6 annual reports, 13 large holders, 53 other. The latest 20:
- Aug 11, 202615-12G EDGAR
- Apr 23, 202620-F EDGAR
- Apr 3, 2026SCHEDULE 13D/A EDGAR
- Aug 19, 20256-K EDGAR
- Apr 25, 202520-F EDGAR
- Jan 21, 2025UPLOAD EDGAR
- Jan 6, 2025CORRESP EDGAR
- Dec 20, 2024CORRESP EDGAR
- Dec 13, 2024SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D EDGAR
- Nov 25, 2024UPLOAD EDGAR
- Nov 18, 2024CORRESP EDGAR
- Nov 5, 2024UPLOAD EDGAR
- Oct 31, 20246-K EDGAR
- Oct 23, 2024CORRESP EDGAR
- Oct 8, 2024CORRESP EDGAR
- Sep 25, 2024UPLOAD EDGAR
- Sep 19, 2024CORRESP EDGAR
- Sep 10, 2024UPLOAD EDGAR
- Aug 27, 2024CORRESP EDGAR
- Aug 16, 20246-K EDGAR
The 72 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)SCHEDULE 13D/A, 4 filings Jul 29, 2022 to Apr 3, 202612
- Australia Wanda International Co LtdSC 13D/A, 1 filing Dec 13, 202413
- Peak Asia Investment Holdings V LtdSC 13D/A, 2 filings Jul 29, 2022 to Aug 17, 202314
- Pengwu ZhouSC 13D, 1 filing Jul 29, 202215
- Wenting DingSC 13D, 1 filing Jul 29, 202216
- Hainan Runming Biotechnology Co., Ltd.SC 13D/A, 2 filings Jun 10, 2022 to Jul 14, 202217
- IDG-Accel China Growth Fund III L.P.SC 13G/A, 2 filings Feb 28, 202218
SEC filer profile
How Aesthetic Medical International Holdings Group Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAesthetic Medical International Holdings Group Ltd1
- CIK0001757143
- Filer statusNon-accelerated filer not an emerging growth company; not a shell company4
- Incorporated inCayman Islands4
- Fiscal year endsDecember 311
- Industry code (SIC)8093 Services-Specialty Outpatient Facilities, NEC1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address1122 Nanshan Avenue, Nanshan District, Shenzhen, Guangdong Province 518000, China1
- Phone917 609-03331
- Shares outstanding147,326,504 shares as of Dec 31, 20254
- AuditorOnestop Assurance PAC, Singapore PCAOB ID 6732; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceDec 7, 20181
- Filings122 in all: 6-K (45), UPLOAD (14), CORRESP (13), 20-F (7), SC 13D/A (6), DRSLTR (5), SC 13D (5), SC 13G (4)1
All 26 form types
DRS/A (3), EFFECT (2), F-1/A (2), SC 13G/A (2), 15-12G (1), 20-F/A (1), 25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), F-1 (1), F-3 (1), F-6 (1), NT 20-F (1), RW (1), S-8 (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (20-F) Apr 23, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| American depositary shares, each representing three ordinary shares | PAIYY | |
| Ordinary shares, par value US$0.001 per share |
From the cover page of the 20-F filed Apr 23, 2026 (Section 12(b) of the Exchange Act).4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18